US drugmakers fall after Trump announces reciprocal tariffs
Shares of some U.S. drugmakers fall between 0.5% and 3.5% after U.S. President Donald Trump speaks on reciprocal tariffs
In extended trading, Johnson & Johnson JNJ.N down 0.6%, Moderna MRNA.O down 3.5%, Eli Lilly LLY.N down 2.4%, Bristol Myers Squibb BMY.N down 0.7% and Regeneron <REGN.O> down 2%
SPDR S&P Biotech ETF falls 4%
Tariffs on major drug trading partners include 20% on EU, 26% on India and 34% on China
*The White House makes clear that pharmaceuticals were exempt from Wednesday's tariffs as Trump plans other sectoral tariffs for semiconductors, pharmaceuticals and potentially critical minerals
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Recommended Articles
Featured Tools
Top News
Allbirds Ditches Sneakers and Pivots to AI Computing - Is BIRD Stock Still Worth Buying After a 600% Surge?

Tesla Q1 2026 Earnings Preview: 50,000-Unit Inventory Overhang, Energy Storage Halved, 5 Core Metrics Long-Term Investors Should Really Watch

Nvidia Launches Ising Model Driving Quantum Sector Surge, QUBT vs IONQ, Which Is More Worth Investing In?

Asia-Pacific Stocks Rise Across the Board Monday as Easing Middle East Tensions Boost Market Sentiment

AST SpaceMobile Shares Plunge in Overnight Trading, What Happened? Will It Affect SpaceX?

Tradingkey







